Drug Type Small molecule drug |
Synonyms UD 014 |
Target |
Action inhibitors |
Mechanism VAP-1 inhibitors(Amine oxidase, copper containing inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metabolic Dysfunction Associated Steatohepatitis | Preclinical | Denmark | 01 Nov 2019 | |
| Diabetic Nephropathies | Preclinical | Japan | 29 Apr 2018 |





